Timing xenotransplantation

© 2005 National Academy of SciencesIsraeli researchers report that embryonic pig tissues used for liver, pancreas, and lung transplants need to come from very specific windows of time in embryonic development.1 The findings offer new insights into organogenesis and might help explain past failures in xenotransplantation, says coauthor Yair Reisner of the Weizmann Institute of Science in Rehovot, Israel.Reisner and his colleagues transplanted pig tissue precursors from embryonic day (E)21 to

Written byCharles Choi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

© 2005 National Academy of Sciences

Israeli researchers report that embryonic pig tissues used for liver, pancreas, and lung transplants need to come from very specific windows of time in embryonic development.1 The findings offer new insights into organogenesis and might help explain past failures in xenotransplantation, says coauthor Yair Reisner of the Weizmann Institute of Science in Rehovot, Israel.

Reisner and his colleagues transplanted pig tissue precursors from embryonic day (E)21 to E100 into immune-deficient mice to identify the optimal windows for the growth of liver, pancreas, and lung. They saw optimal liver growth and function at E28, with enzyme-linked immunosorbent assay (ELISA) showing rapid decrease of secreted albumin levels from implants past that stage. In contrast, development of mature lung tissue was not observed via stained micrographs until relatively late in gestation at E56. Maximal pancreas growth and function was seen from E42 to E56, with ELISA revealing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies